Article
The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient.
Human molecular genetics - 1 Sept 1994
Pritchard-Jones K, Renshaw J, King-Underwood L
Abstract excerpt
The Wilms tumour (WT1) gene was first localized through its deletion in individuals with the WAGR syndrome (Wilms tumour, aniridia, genitourinary abnormalities and mental retardation). Such individuals have a 30-50% lifetime risk of developing Wilms tumour and carry constitutional interstitial deletions of chromosome 11p13, including the WT1 gene. Second primary tumours occurring in such individuals might also be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
